Patient Data. Within fifty-five (55) days of the end of each fiscal quarter and to the extent not included in the operating statements delivered pursuant to subsection (i), above, a statement of the actual patient days incurred for the quarter, together with quarterly census information for the Facilities as of the end of such quarter by patient- mix (i.e., private, Medicare, Medicaid and V.A.) of the Facilities.
Patient Data. Healthcare Entity shall not, either directly or indirectly, itself or through any agents or third party, request, scrape, export, compile, store, maintain or in any way take into its electronic systems any of the patient personal data, PHI, and patient security information to which it is given access through the Gateway Service. This specifically includes any prescription data provided to the Healthcare Entity by the PMP Gateway. This section does not bar Authorized Users from making clinical notes referencing the information accessed through the Gateway Service in order to reflect analysis and clinical decision making relevant to patient care and treatment.
Patient Data. Pfizer and PDI shall maintain the security and confidentiality of all Patient Data, in accordance with all applicable agreements, state and Federal laws, patient release forms, and the provisions of this Agreement. In furtherance of the foregoing, each party covenants, represents and warrants that (a) any Patient Information that is acquired will be used and disclosed only (i) as permitted under HIPAA and other laws, as applicable, and (ii) as Pfizer lawfully authorizes and directs; and (b) Patient Information will be stored, secured and transmitted in compliance with the lawful instructions of Pfizer and in compliance with their respective privacy policies. Each of PDI, on one hand, and Pfizer on the other hand, shall indemnify, defend, and hold harmless the other from any claims, penalties, liabilities, losses, damages, settlements, or costs which may arise from its’ use or disclosure of Patient Information in violation of this Section 6.6. To the extent necessary for PDI to perform the Services, Pfizer and PDI shall develop jointly one or more patient release forms satisfactory to both parties to be used by PDI in performing the Services to permit the sharing of Patient Data among the parties.
Patient Data. Any piece of information, administrative or medical, specific to an incarcerated public offender receiving medical or surgical treatment in a hospital, office, clinic, or hospital outpatient surgery center.
Patient Data. In connection with your use of the Software, unless provided otherwise in separate documentation provided to you in this respect, you will transmit, disclose, submit, or exchange certain health information relating to the measurements and anatomy of your patients (“Patient Data”) to Xxxxxx and/or any of its affiliates and third party subcontractors (“Recipients”) for the implant procedure, customization of the implant, custom implant tools, advance planning of implant procedures, matching of implants with patient anatomy for your procedure for the applicable patient and analysis related to implant outcomes, and related health care operations, such as for purposes of statistical analysis, future implant design, reference, research, data analysis, and software improvement. You are solely responsible for the accuracy and contents of the Patient Data transmitted to the Recipients. You will limit the Patient Data transmitted to the Recipients to that which is necessary for the services described in this Agreement, and will not disclose any directly identifiable data or any sensitive data related to sexually transmitted diseases, HIV/AIDS status, alcohol and drug abuse records governed by 42 C.F.R. Part 2, psychotherapy notes as defined by 45 C.F.R. § 164.501, behavioral health information, Social Security Numbers, financial account information, or any other personally identifiable information not necessary for the purposes described in this Agreement..
Patient Data. Each party agrees that patient clinical information, Laboratory Orders, Laboratory Results Reports, and all patient-related information, including any derivatives resulting from the manipulation or compilation thereof ("Patient Data") are Confidential Information (as defined herein) and each party agrees it will not disclose or utilize individual laboratory test information or other Patient Data in any way that would violate any patient confidentiality obligations or any Applicable Laws, as defined above. Without limiting MedPlus' obligations regarding Confidential Information which may be otherwise provided for in this Agreement, MedPlus shall be responsible to ensure the confidentiality and security of Patient Data transmitted or otherwise available to MedPlus in any form, manner, on any media, and in any format now known or hereafter developed, in accordance with all Applicable Laws governing such Patient Data now or in the future, including those to prevent anyone other than the sender and addressee of each Transaction or their respective authorized employees from monitoring, using, gaining access to or learning the import or contents of any Transaction. Notwithstanding the foregoing, but subject to the restrictions of the foregoing, the parties recognize that MedPlus, its employees and agents and permitted assigns, who have a need to know, will have access to the Patient Data for the sole purpose of performing MedPlus' obligations under this Agreement. All Patient Data associated with Laboratory Orders, Laboratory Results Reports, and all information contained in Transactions ("Quest Diagnostics Patient Data"), shall be owned by Quest Diagnostics and not by MedPlus. Except as otherwise specifically contemplated by this Agreement, MedPlus shall not aggregate, integrate, compile, regenerate, merge, manipulate or otherwise use the Quest Diagnostics Patient Data for any purposes, including to derive revenue therefrom, and shall not provide the Quest Diagnostics Patient Data to any other person or entity, other than as specifically required or allowed under the terms of this Agreement to perform the services hereunder, without the prior written consent of Quest Diagnostics. MedPlus agrees that Quest Diagnostics Patient Data cannot be aggregated for any third party, including but not limited to any Provider, or among different customers of MedPlus or other health care providers, payors or laboratory service providers for any purpose, without Quest Diagnosti...
Patient Data. As between the Parties, Participant is the sole and exclusive owner of any and all updates or modifications to or derivatives of any of the Patient Data provided by Participant (“Participant Patient Data”), which updates, modifications, or derivatives are made by or for SACVALLEY MEDSHARE, and all intellectual property rights in the foregoing, whether or not provided to any other party under this Agreement. All such updates, modifications, and derivatives constitute Participant Patient Data hereunder. To the extent SACVALLEY MEDSHARE at any time has any rights in or to any Participant Patient Data (including intellectual property rights), SACVALLEY MEDSHARE hereby assigns to Participant all such rights. Upon Participant’s request any time (including in connection with investigations, audits, and compliance with Applicable Laws) and at the end of the Term to which such Participant Patient Data pertains, SACVALLEY MEDSHARE shall promptly provide to Participant, at no additional charge, an electronic copy of all Participant Patient Data, and all other Patient Data pertaining to Patients attributable to Participant, in the format and with the file layouts reasonably requested by Participant, provided that SACVALLEY MEDSHARE is reasonably capable of producing the data in that format and layout. If Participant requests at any time, SACVALLEY MEDSHARE shall destroy all copies of Participant Patient Data in SACVALLEY MEDSHARE’s possession or control. SACVALLEY MEDSHARE shall not use Patient Data for any purpose other than that of rendering services under this Agreement, nor sell, assign, lease, dispose of or otherwise exploit Patient Data. SACVALLEY MEDSHARE shall not possess or assert any lien or other right against or to Patient Data. SACVALLEY MEDSHARE Will Cause ICA to comply with and perform SACVALLEY MEDSHARE’s obligations under this Section 10.5.
Patient Data. Strongbridge shall comply with all applicable laws, rules and regulations, as amended from time to time, with respect to the use and disclosure of individually identifiable health information contained in the Regulatory Approval, and ensure that: (a) such information is used and/or disclosed only in accordance with applicable law or regulation; and (b) all appropriate technical and organizational measures are taken to protect such information against accidental, unauthorized or unlawful destruction, loss, alteration, access or disclosure.
Patient Data. Podimetrics receives, transmits, and uses certain patient data to you and/or third parties. The privacy and security of such data is subject to the terms of our Privacy Policy.
Patient Data. Our Products and Services will automatically collect Patient Data, including foot temperature when using a Device. • Patients, healthcare providers and authorized distributors of the Products and/or Services (“Distributors”) may also provide us other Patient Data in connection with the use of our Products and Services, including but not limited to information collected in the course of providing support or monitoring related to an individual’s use of the Products and Services, such as photographs taken by Distributors or healthcare providers during in-person training, fol- low-up, or support visits.
